NEW YORK (GenomeWeb News) – Genomics services provider ImaGenes has received certification from Roche NimbleGen to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services, Roche NimbleGen said today.

Berlin-based ImaGenes passed a ChIP-chip certification using the NimbleGen Dual-Color workflow and the MS 200 Microarray Scanner to become a certified service provider. This certification enables ImaGenes to process samples for DNA-protein interactions and chromatin structure.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.